Atlas Trials

Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study

Clinical trial NCT00169598 · UNKNOWN

Trial details

NCT number
NCT00169598
Sponsor
Hospices Civils de Lyon
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma
Start date
2002-02-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.